Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.76 SEK 0.78% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Total Receivables
kr1.6m
CAGR 3-Years
-12%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Receivables
kr133.9m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Receivables
kr224.6m
CAGR 3-Years
70%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Receivables
kr708m
CAGR 3-Years
44%
CAGR 5-Years
23%
CAGR 10-Years
25%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Receivables
kr8.1B
CAGR 3-Years
27%
CAGR 5-Years
24%
CAGR 10-Years
29%
BioArctic AB
STO:BIOA B
Total Receivables
kr7.1m
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.8B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.86 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Total Receivables?
Total Receivables
1.6m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Total Receivables amounts to 1.6m SEK.

What is Vicore Pharma Holding AB's Total Receivables growth rate?
Total Receivables CAGR 5Y
6%

Over the last year, the Total Receivables growth was 3%. The average annual Total Receivables growth rates for Vicore Pharma Holding AB have been -12% over the past three years , 6% over the past five years .

Back to Top